[1] TOMATIS L. IARC benzene report[J]. Science,1982,218(4569):214. [2] SMITH M T. Overview of benzene-induced aplastic anaemia[J]. Eur J Haematol,1996,57:107-110. [3] SNYDER R,HEDLI C C. An overview of benzene metabolism[J]. Environ Health Perspect,1996,104(6):1165-1171. [4] SNYDER R. Leukemia and benzene[J]. Int J Environ Res Public Health,2012,9(8):2875-2893. [5] MCHALE C M,ZHANG L,SMITH M T. Current understanding of the mechanism of benzene-induced leukemia in humans:implications for risk assessment[J]. Carcinogenesis, 2012,33(2):240-252. [6] RICHARDSON C,YAN S,VESTAL C G. Oxidative stress,bone marrow failure,and genome instability in hematopoietic stem cells[J]. Int J Mol Sci,2015,16(2):2366-2385. [7] ZHAO Z,HE X,BI Y,et al. Induction of CYP4F3 by benzene metabolites in human white blood cells in vivo in human promyelocytic leukemic cell lines and ex vivo in human blood neutrophils[J]. Drug Metab Dispos,2009,37(2):282-291. [8] MENG X,ZHANG J,YIN L H,et al. Involvement of hypoxia-inducible factor-1 alpha (HIF-1 alpha) in inhibition of benzene on mouse hematopoietic system[J]. J Toxicol Environ Health A,2016,79(9/10):402-406. [9] TESTA U,LABBAYE C,CASTELLI G,et al. Oxidative stress and hypoxia in normal and leukemic stem cells[J]. Exp Hematol,2016,44(7):540-560. [10] SPENCER J A,FERRARO F,ROUSSAKIS E,et al. Direct measurement of local oxygen concentration in the bone marrow of live animals[J]. Nature,2014,508(7495):269-273. [11] WU C,ZHOU Y,FAN W,et al. Hypoxia-mimicking mesoporous bioactive glass scaffolds with controllable cobalt ion release for bone tissue engineering[J]. Biomaterials,2012,33(7):2076-2085. [12] LI T S,HAMANO K,SUZUKI K,et al. Improved angiogenic potency by implantation of ex vivo hypoxia prestimulated bone marrow cells in rats[J]. Am J Physiol Heart Circ Physiol,2002,283(2):468-473. [13] HU C J,IYER S,SATAUR A,et al. Differential regulation of the transcriptional activities of hypoxia-inducible factor 1 alpha (HIF-1alpha) and HIF-2alpha in stem cells[J]. Mol Cell Biol,2006,26(9):3514-3526. [14] JENNIFER M. S,JONATHAN H,PRATIBHA S,et al. Pharmacologic increase in HIF1a enhances hematopoietic stem and progenitor homing and engraftment[J]. Blood,2014,123(2):203-207. [15] 吴小荣,李晓飞,韩庆玲. 甲基化抑制剂对氢醌抑制K562细胞红系分化的干预作用[C]//全国生化/工业与卫生毒理学学术会议论文集. 大连:中国毒理学会,2010:241-242. [16] 薛明,张光垚,吴晓荣. 苯代谢物苯酚对K562细胞的凋亡诱导和分化抑制作用[C]//中国毒理学会第五次全国学术大会论文集. 贵阳:中国毒理学会,2009:70. [17] 韩庆玲,薛明,吴晓荣. 苯代谢物苯酚对K562细胞的凋亡诱导作用[C]//中国毒理学会第五次全国学术大会论文集. 贵阳:中国毒理学会,2009:138. [18] JIANG Y Z,LI Y,WANG K,et al. Distinct roles of HIF1A in endothelial adaptations to physiological and ambient oxygen[J]. Mol Cell Endocrinol,2014,391(1/2):60-67. [19] CHEN H,SHEN Y,GONG F,et al. HIF-alpha promotes chronic myelogenous leukemia cell proliferation by upregulating p21 expression[J]. Cell Biochem Biophys,2015,72(1):179-183. [20] ZHANG H J,LI H W,S. XI H L,et al. HIF1α is required for survival maintenance of chronic myeloid leukemia stem cells[J]. BLOOD,2012,119(11):2595-2607. |